Search bioRxiv⌕ Search

Biology subjects

Jorgensen, A. L.

Publications and source records attributed to Jorgensen, A. L..

2 recordsLinked to original sources

Evaluating the utility of amino acid similarity-aware kmers to represent TCR repertoires for classification

Insights gained through interpretation of models trained on the T-cell receptor (TCR) repertoire contribute to advances in understanding of immune-mediated disease. This has the potential to improve diagnostic tests and treatments, particularly for autoimmune diseases. However, TCR repertoire datasets with samples from donors of known autoimmune disease status generally include orders of magnitude fewer samples than TCR sequences. Promising TCR repertoire classification approaches consider relationships between non-identical TCR sequences. In particular, kmer methods demonstrate strong and stable performance for small datasets. We propose a TCR repertoire representation that considers the relationships between amino acids within kmers flexibly and efficiently, which makes exploration of a wide range of TCR sequence features feasible. XGBoost models are trained and tested on kmer representations of TCR repertoire datasets including samples from patients with coeliac disease as well as donors with previous cytomegalovirus infection. We show that kmers that use small representative alphabets of amino acids are capable of training models that perform similarly or better than kmers based on all 20 amino acids. We find that, for cytomegalovirus infection status classification, defining amino acid relationships using BLOSUM62 can lead to a model with stronger performance as compared to an Atchley factor definition. Finally, we detail kmers or motifs which are important in each classification model and highlight the challenge of training truly interpretable TCR repertoire classification models which, if overcome, could lead to biomarker discovery for autoimmune diseases. Author summaryTCR repertoire classification models can provide valuable understanding of autoimmune diseases if they can accurately infer autoimmune disease status and are biologically interpretable. Based on a kmer representation of the TCR repertoire, which has been shown to be most appropriate to train classification models on smaller datasets, we develop a computationally efficient method of grouping amino acid sequences to add knowledge to immune status classification model inputs, and consider its effect on interpretability. We find that most of the 4mer-based feature types we tested perform well in combination with an XGBoost model, where some benefit may be gained by applying a greatly-reduced alphabet of amino acids based on BLOSUM62 for cytomegalovirus serostatus classification. Our proposed reduced alphabet methodology is an alternative to kmer clustering which allows more efficient exploration of amino acid relationships and results in a more interpretable feature space.

immunology↗

Association of variants within the GST and other genes with anti-tubercular agents related toxicity: a systematic review and meta-analysis

BackgroundIndividuals receiving treatment with anti-tuberculosis (TB) drugs may experience serious side-effects, such as anti-TB drug-induced hepatotoxicity (ATDH). Genetic variants, such as polymorphisms of the GST gene and other genes, may increase the risk of experiencing such toxicity events. This systematic review and meta-analysis provides a comprehensive evaluation of the evidence base for associations between variants of the GST gene and other genes and toxicity outcomes related to anti-TB drugs.\n\nMethodsWe searched for relevant studies in MEDLINE, PubMed, EMBASE, BIOSIS and Web of Science. We pooled effect estimates for each genotype on each outcome, and stratified all analyses by country. We qualitatively assessed the methodological quality of the included studies.\n\nResultsWe included data from 28 distinct cohorts of patients in the review. The methodological quality of included studies was variable, with several important areas of concern. For GSTM1, patients with the homozygous null genotype were significantly more likely to experience hepatotoxicity than patients with heterozygous or homozygous present genotype (odds ratio [OR]=1.44, 95% confidence interval [CI] 1.15, 1.82). Moderate heterogeneity was observed in this analysis (I2=51.2%). No significant difference was observed for the GSTT1 null polymorphism. For the rs3814057 polymorphism of the PXR gene, both heterozygous genotype and homozygous mutant-type significantly increased hepatotoxicity risk compared with homozygous wild-type (heterozygous versus homozygous wild-type: OR=1.98, 95% CI 1.06, 3.69; I2=0%; homozygous mutant-type versus homozygous wild-type: OR=2.18, 95% CI 1.07, 4.44; I2=0%).\n\nConclusionsWe found that it is challenging to perform robust synthesis of the evidence base for associations between GST and other genetic variants and toxicity related to anti-TB drugs. We identified significant associations between the GSTM1 null and PXR rs3814057 polymorphisms and ATDH. To the best of our knowledge, no meta-analyses on genetic variants other than variants of the NAT2, CYP2E1, GSTM1 and GSTT1 genes have been published. Our results therefore add to the existing understanding of the association between genetic variants and hepatotoxicity.

genetics↗